Michigan State University
Also known as: Fiechtner, Justus J., M.D., P.C. | Gary E. Stein, Pharm.D. | Helen DeVos Children's Hospital | Helen DeVos Childrens Hospital | Helen DeVos Children's Hospital at Spectrum Health | Helen DeVos Children's Hospital of Spectrum Health Hospitals | Justus Fiechtner MD PC | Justus J. Fiechtner, MD, PC | Michigan State University | MichiganState University | Michigan State University. Assistant Chair-Dept of Obstetrics, Gynecology&Reproductive Biology
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2004Last known activity
Aug 7, 2025
Timeline
1850s
- Jan 1, 1855
Michigan State University— Founded
Drugs by trial phase (52 distinct, 38 trials)
Phase 4 (22 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (17 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Alcoholism
- Alzheimer Disease
- Arthritis
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Brain Edema
- Brain Injuries
- Brain Injuries, Traumatic
- Bronchiolitis
- Bronchiolitis, Viral
- Candidemia
- Central Nervous System Neoplasms
- Cognitive Dysfunction
- Critical Illness
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Edema
- Emergencies
- Febrile Neutropenia
- Fever
- Glioma
- Headache
- Hypertension
- Infertility
- Inflammatory Bowel Diseases
- Intestinal Diseases
- Intracranial Hypertension
- Kidney Diseases
- Kidney Failure, Chronic
- Lupus Erythematosus, Systemic
- Macular Edema
- Malaria
- Malaria, Cerebral
- Marijuana Abuse
- Multiple Sclerosis
- Nervous System Neoplasms
- Neurofibroma
- Neurofibromatoses
- Neurofibromatosis 1
- Neutropenia
- Pneumonia
- Pneumonia, Bacterial
- Post-Concussion Syndrome
- Prostatic Neoplasms
- Schizophrenia
- Sclerosis
- Wounds and Injuries
Recent trials (50)
- NCT07013565CollaboratorPhase 2Aug 7, 2025
- NCT06424002CollaboratorPhase 4Jun 1, 2024
- NCT06595745Lead sponsorN/AMay 28, 2024
- NCT06595745Sponsor investigatorN/AMay 28, 2024
- NCT05700643Reponsible party - principal investigatorPhase 1/Phase 2Jan 18, 2023
- NCT05700643Lead sponsorPhase 1/Phase 2Jan 18, 2023
- NCT05331144Overall official - principal investigatorPhase 2Oct 25, 2022
- NCT05331144CollaboratorPhase 2Oct 25, 2022
- NCT04972942Study chairPhase 2Sep 30, 2021
- NCT05399290Overall official - principal investigatorPhase 4Nov 19, 2020
- NCT05399290Reponsible party - principal investigatorPhase 4Nov 19, 2020
- NCT05399290Lead sponsorPhase 4Nov 19, 2020
- NCT03385590CollaboratorN/AJun 21, 2018
- NCT04292535Reponsible party - principal investigatorPhase 2Jun 15, 2018
- NCT04292535Overall official - principal investigatorPhase 2Jun 15, 2018
Details
- Founded
- East Lansing, MI, US Jan 1, 1855
- Last known activity
- Aug 7, 2025